Your session is about to expire
← Back to Search
Mindful Self-Compassion for Anxiety and Depression
N/A
Recruiting
Led By Elizabeth Hoge, MD
Research Sponsored by Georgetown University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 8 weeks
Awards & highlights
No Placebo-Only Group
Summary
This trial will compare the effect of a Mindful Self-Compassion training program on anxiety and depression in people with anxiety or depression disorders.
Who is the study for?
This trial is for adults with anxiety disorders (like social anxiety, generalized anxiety, panic disorder, or agoraphobia) or major depression who feel they aren't very self-compassionate. Participants must understand the study and agree to all parts of it. People can't join if they've had certain mental health treatments recently, have severe medical conditions that could interfere, are pregnant, prisoners, or plan to be away during the study.
What is being tested?
The trial tests an 8-week Mindful Self-Compassion program against a control group not receiving this training. It aims to see if this approach helps reduce symptoms of anxiety and depression in participants compared to those who don’t receive the intervention.
What are the potential side effects?
Mindful Self-Compassion is generally considered safe but may bring up uncomfortable emotions temporarily as individuals learn to cope with their feelings more compassionately.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 8 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~8 weeks
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Hospital Anxiety and Depression Scale
Secondary study objectives
Self-compassion Scale
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Mindful Self-CompassionExperimental Treatment1 Intervention
Mindful Self-Compassion (MSC) is a weekly class given for 8 weeks. The individual classes last about 2 hours each. The class is provided in a group setting.
Group II: Treatment as Usual (TAU)Active Control1 Intervention
The TAU arm will not receive the additional treatment from the study. Subjects will receive psychiatric treatment from their usual providers.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Mindful Self-Compassion
2020
N/A
~650
Find a Location
Who is running the clinical trial?
Georgetown UniversityLead Sponsor
348 Previous Clinical Trials
137,262 Total Patients Enrolled
4 Trials studying Depression
2,453 Patients Enrolled for Depression
Elizabeth Hoge, MDPrincipal InvestigatorGeorgetown University
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have had serious thoughts or actions of suicide in the last year.I can understand and agree to the study's procedures.I started psychotherapy for anxiety within the last month or am currently in such therapy.I am unable to give consent for medical procedures or treatments.I have completed a meditation course similar to MSC within the last year.I understand the study procedures and consent process and do not have significant personality issues.I have a serious health issue that might need surgery or a hospital stay.I have been diagnosed with a primary anxiety disorder or major depression.I do not have a psychiatric disorder other than anxiety or depression.I am on stable doses of certain psychiatric meds, including sleep aids or antidepressants, for 8 weeks.
Research Study Groups:
This trial has the following groups:- Group 1: Mindful Self-Compassion
- Group 2: Treatment as Usual (TAU)
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Depression Patient Testimony for trial: Trial Name: NCT05671419 — N/A
Other Trials to Consider
Popular Categories
Learn More About These Treatments
Share this study with friends
Copy Link
Messenger